Locally advanced head and neck squamous cell carcinoma
Clinical trials for Locally advanced head and neck squamous cell carcinoma explained in plain language.
Never miss a new study
Get alerted when new Locally advanced head and neck squamous cell carcinoma trials appear
Sign up with your email to follow new studies for Locally advanced head and neck squamous cell carcinoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can immunotherapy before surgery shrink head and neck tumors?
Disease control OngoingResearchers are testing whether adding the immunotherapy drug toripalimab to standard chemotherapy (gemcitabine and cisplatin) before surgery can help patients with locally advanced head and neck squamous cell carcinoma. The trial enrolls about 20 adults whose tumors can be remov…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Phase 1 • Sponsor: Fifth Affiliated Hospital, Sun Yat-Sen University • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
New combo therapy offers hope for head and neck cancer patients unable to take standard chemo
Symptom relief OngoingThis early-phase study tests the safety of combining the drug tolinapant with radiation therapy for people with head and neck cancer that has spread locally but hasn't been treated yet. Participants are those who cannot receive the standard chemotherapy drug cisplatin. The goal i…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Early phase 1 • Sponsor: Emory University • Aim: Symptom relief
Last updated Aug 23, 2026 00:00 UTC
-
AI model aims to end guesswork in head and neck cancer care
Knowledge-focused By invitation onlyThis study uses an AI model to analyze patient data and recommend the best follow-up treatment after surgery for advanced head and neck cancer. Researchers will track 571 patients over two years to see if the AI's suggestions improve survival and reduce recurrence. The goal is to…
Matched conditions: LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA
Sponsor: Nanfang Hospital, Southern Medical University • Aim: Knowledge-focused
Last updated Jul 22, 2026 00:00 UTC